Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cuthbertson

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
Diabetes Care|May 2, 2012
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|June 18, 2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|February 25, 2018
Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 11, 2022
Serum 25-hydroxyvitamin D and fatty acids in relation to the risk of microbial infections in children: The TRIGR Divia studyLeena Hakola, Maarit Oikarinen, Sari Niinistö, et al.
Diabetes Care|July 30, 2021
<i>TCF7L2</i> Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 DiabetesMaria J Redondo, Megan V Warnock, Ingrid M Libman, et al.
Diabetes Care|March 31, 2023
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet AutoantibodiesJay M Sosenko, David Cuthbertson, Emily K Sims, et al.
Diabetes Care|March 1, 2006
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Carla J Greenbaum, et al.
Plos One|March 27, 2015
Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Christian Dejaco, Bastian Oppl, Paul Monach, et al.
Pediatric Diabetes|February 5, 2021
Serum fatty acids and risk of developing islet autoimmunity: A nested case-control study within the TRIGR birth cohortLeena Hakola, Iris Erlund, David Cuthbertson, et al.
Diabetes Care|December 29, 2006
Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Carla J Greenbaum, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
Diabetes Care|May 2, 2012
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetesJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|June 18, 2011
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History StudyJay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Diabetes Care|February 25, 2018
Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787Jay M Sosenko, Jay S Skyler, Jeffrey Mahon, et al.
Clinical Nutrition (Edinburgh, Scotland)|November 11, 2022
Serum 25-hydroxyvitamin D and fatty acids in relation to the risk of microbial infections in children: The TRIGR Divia studyLeena Hakola, Maarit Oikarinen, Sari Niinistö, et al.
Diabetes Care|July 30, 2021
<i>TCF7L2</i> Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 DiabetesMaria J Redondo, Megan V Warnock, Ingrid M Libman, et al.
Diabetes Care|March 31, 2023
Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet AutoantibodiesJay M Sosenko, David Cuthbertson, Emily K Sims, et al.
Diabetes Care|March 1, 2006
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Carla J Greenbaum, et al.
Plos One|March 27, 2015
Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Christian Dejaco, Bastian Oppl, Paul Monach, et al.
Pediatric Diabetes|February 5, 2021
Serum fatty acids and risk of developing islet autoimmunity: A nested case-control study within the TRIGR birth cohortLeena Hakola, Iris Erlund, David Cuthbertson, et al.
Diabetes Care|December 29, 2006
Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Carla J Greenbaum, et al.
Pageof 15